ADTX News and Press, ADiTx Therapeutics Inc. From 09/29/22

Aditxt ( NASDAQ: ADTX ) shares are surging 26% on receiving Nasdaq confirmation that the company has regained compliance with the minimum bid price requirement and meets all other applicable criteria for continued listing. The company recently complet...

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces it has received confirmation from The Nasdaq Sto...

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system. The company today provided shareholders with a corporate update following the completion of a reverse stock split and closing of a previ...

Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today provides shareholders with a corporate update following the com...

3 Top Penny Stocks to Add to Your Watchlist Right Now When it comes to buying penny stocks, knowing what is going on in the stock market is crucial. This means having a thorough understanding of the latest market news and events. While there are a number of ways to get this information,...

A team of scientists at the University of British Columbia has revealed that it is close to developing an insulin pill. Insulin is a hormone the pancreas produces. This hormone is used to control the amount of sugar or glucose in the blood. Insulin deficiency can cause increased blood sug...

Aditxt Inc. (NASDAQ: ADTX) , a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has closed on its recent public offering. The offering was comprised of 3,333,333 shares of common stock or common stock equival...

Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering ...

Last week, the United States clocked one million organ transplants. This historic milestone was confirmed by the United Network for Organ Sharing at 12.50 p.m. ET. This private nonprofit organization is in charge of managing the sole organ transplantation and procurement network in the U...

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has released the pricing of its public offering. The offering consists of 3,333,333 shares of its comm...